SMP-656 for HER2-Positive Advanced Breast Cancer

Clinical trial NCT07726342 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07726342
Sponsor: Chengdu SciMount Pharmatech Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-positive Breast Cancer Metastatic Breast Cancer Locally Advanced Breast Cancer (LABC)

Start date: 2026-07-16
Primary completion: 2027-07-07
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.